NL-OMON32761招募中不适用
DOSING AND PHARMACOKINETICS OF INTRAVENOUS AMOXICILLIN IN CHILDREN - dosing/pharmacokinetics of intravenous amoxicillin in children
Canisius Wilhelmina Ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •1. Patients who receive intravenous treatment with amoxicillin
- •2. Patients < 18 years
- •3. Written informed consent from the patient and/or their legal guardian
排除标准
- •Patients with a known allergy to amoxicillin or related compounds
研究者
相似试验
进行中（未招募）
1 期
Amoxicillin/clavulanic acid in sepsis and septic shockSepsis and septic shockEUCTR2016-002195-27-EEniversity of Tartu
进行中（未招募）
不适用
Absorption of Amoxicillin tablets in overweight volunteersC18.654.726.500ObesityRBR-4n2c59Hospital Universitário Regional de Maringá
已完成
3 期
Pharmacokinetics and safety of the intravenous human immunoglobulin product Nanogam 100 mg/mlcongenital antibody immune disorderprimary hypogammaglobulinemia1002142910021460NL-OMON38799Sanquin Bloedvoorziening20
进行中（未招募）
不适用
The pharmacokinetics (the behaviour in the body) and safety of the intravenous immunoglobulin product Nanogam 100 mg/mlEUCTR2012-005727-32-NLSanquin Blood Supply Foundation
已完成
不适用
Pharmacokinetics and -dynamics of needlefree apomorphine administration vs. subcutaneous injections with apomorphine in patients with Parkinson*s disease; a pilot study with a new device10028037Parkinson's DiseaseNL-OMON35723niversitair Medisch Centrum Groningen10